Who is the right patient for TAVI?

Journal of Cardiology

Volumn 63, Issue 3, 2014, Pages 178-181

  Arai, Takahide ^a   Lefèvre, Thierry ^a  

^a INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

Author keywords

Aortic stenosis; Heart team approach; Screening; Transcatheter aortic valve implantation

Indexed keywords

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CORONARY ARTERY DISEASE; DILATATION; EUROSCORE; EVALUATION STUDY; HEART VALVE BIOPROSTHESIS; HUMAN; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATIENT SELECTION; PERCUTANEOUS AORTIC VALVE; REVIEW; SELF EXPANDING STENT; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS;

AORTIC STENOSIS; HEART TEAM APPROACH; SCREENING; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; FEASIBILITY STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; RISK; SEVERITY OF ILLNESS INDEX;

EID: 84896738614     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.11.005     Document Type: Review

References (19)

1. Webb J., Cribier A. Percutaneous transarterial aortic valve implantation: what do we know. Eur Heart J 2011, 32:140-147.
2. Moat N.E., Ludman P., de Belder M.A., Bridgewater B., Cunningham A.D., Young C.P., Thomas M., Kovac J., Spyt T., MacCarthy P.A., Wendler O., Hildick-Smith D., Davies S.W., Trivedi U., Blackman D.J., et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011, 58:2130-2138.
3. Zahn R., Gerckens U., Grube E., Linke A., Sievert H., Eggebrecht H., Hambrecht R., Sack S., Hauptmann K.E., Richardt G., Figulla H.R., Senges J. German Transcatheter Aortic Valve Interventions-Registry I. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011, 32:198-204.
4. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., Seeman T., Tracy R., Kop W.J., Burke G., McBurnie M.A. Cardiovascular Health Study Collaborative Research G. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146-M156.
5. Nashef S.A., Roques F., Sharples L.D., Nilsson J., Smith C., Goldstone A.R., Lockowandt U. EuroSCORE II. Eur J Cardio-thorac Surg 2012, 41:734-744.
6. Watanabe Y., Hayashida K., Lefevre T., Chevalier B., Hovasse T., Romano M., Garot P., Farge A., Donzeau-Gouge P., Bouvier E., Cormier B., Morice M.C. Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2013, 81:1053-1060.
7. Durand E., Borz B., Godin M., Tron C., Litzler P.Y., Bessou J.P., Dacher J.N., Bauer F., Cribier A., Eltchaninoff H. Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 2013, 111:891-897.
8. Yamamoto M., Hayashida K., Mouillet G., Hovasse T., Chevalier B., Oguri A., Watanabe Y., Dubois-Rande J.L., Morice M.C., Lefevre T., Teiger E. Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. J Am Coll Cardiol 2013, 62:869-877.
9. Yamamoto M., Hayashida K., Mouillet G., Chevalier B., Meguro K., Watanabe Y., Dubois-Rande J.L., Morice M.C., Lefevre T., Teiger E. Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation. JACC Cardiovasc Interv 2013, 6:479-486.
10. Wenaweser P., Pilgrim T., Guerios E., Stortecky S., Huber C., Khattab A.A., Kadner A., Buellesfeld L., Gloekler S., Meier B., Carrel T., Windecker S. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention 2011, 7:541-548.
11. Stefanini G.G., Stortecky S., Meier B., Windecker S., Wenaweser P. Severe aortic stenosis and coronary artery disease. EuroIntervention 2013, 9(Suppl.):S63-S68.
12. Hayashida K., Lefevre T., Chevalier B., Hovasse T., Romano M., Garot P., Mylotte D., Uribe J., Farge A., Donzeau-Gouge P., Bouvier E., Cormier B., Morice M.C. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 2011, 4:851-858.
13. Achenbach S., Delgado V., Hausleiter J., Schoenhagen P., Min J.K., Leipsic J.A. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr 2012, 6:366-380.
14. Watanabe Y., Morice M.C., Bouvier E., Leong T., Hayashida K., Lefevre T., Hovasse T., Romano M., Chevalier B., Donzeau-Gouge P., Farge A., Cormier B., Garot P. Automated 3-dimensional aortic annular assessment by multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc Interv 2013, 6:955-964.
15. Hayashida K., Lefevre T., Chevalier B., Hovasse T., Romano M., Garot P., Bouvier E., Farge A., Donzeau-Gouge P., Cormier B., Morice M.C. Impact of post-procedural aortic regurgitation on mortality after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2012, 5:1247-1256.
16. Kodali S.K., Williams M.R., Smith C.R., Svensson L.G., Webb J.G., Makkar R.R., Fontana G.P., Dewey T.M., Thourani V.H., Pichard A.D., Fischbein M., Szeto W.Y., Lim S., Greason K.L., Teirstein P.S., et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012, 366:1686-1695.
17. Hayashida K., Bouvier E., Lefevre T., Hovasse T., Morice M.C., Chevalier B., Romano M., Garot P., Mylotte D., Farge A., Donzeau-Gouge P., Cormier B. Impact of CT-guided valve sizing on post-procedural aortic regurgitation in transcatheter aortic valve implantation. EuroIntervention 2012, 8:546-555.
18. Hayashida K., Lefevre T. Treatment and prevention of aortic regurgitation after transcatheter aortic valve implantation. EuroIntervention 2012, 8(Suppl. Q):Q34-Q40.
19. Nombela-Franco L., Rodes-Cabau J., DeLarochelliere R., Larose E., Doyle D., Villeneuve J., Bergeron S., Bernier M., Amat-Santos I.J., Mok M., Urena M., Rheault M., Dumesnil J., Cote M., Pibarot P., et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv 2012, 5:499-512.